ACCURASEE PACKAGING & LABELING - Trademark Details
Status: 809 - SU - Final Refusal - Mailed
Image for trademark with serial number 87756940
Serial Number
87756940
Word Mark
ACCURASEE PACKAGING & LABELING
Status
809 - SU - Final Refusal - Mailed
Status Date
2021-08-26
Filing Date
2018-01-16
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
261709, 261713 - Curved line(s), band(s) or bar(s). Letters or words underlined and/or overlined by one or more strokes or lines.
Published for Opposition Date
2018-06-19
Law Office Assigned Location Code
M80
Employee Name
LEASER, ANDREW C
Statements
Indication of Colors claimed
The colors black and red are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PACKAGING & LABELING"
Description of Mark
The mark consists of the wording "AccuraSEE" in larger italicized font and the wording "PACKAGING & LABELING" in smaller font below the right portion of the wording "AccuraSEE". The term "Accura" is in black and the terms "SEE" and "PACKAGING & LABELING" are in red. The slash in the first letter "A" in "Accura" curves down and across the entire lower portion of the mark.
Goods and Services
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Dermatological pharmaceutical products; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of joint disease; Intravenous fluids used for the delivery of pharmaceutical preparations; Intravenous bags, syringes, and vials sold filled with injectable pharmaceutical preparations, namely, oncologic products and ancillary products, chemotherapy agents, anti-emitics, and anti-infectives; Anticholinergics; Anticholinesterases; Anti-hypotensives; Biological preparations for the treatment of cancer; Anesthetics for surgical and non-surgical use; Antibiotics; Antiemetics; Sedatives; all of the foregoing featuring differentiated packaging for the purpose of reducing user errors and promoting correct medication selection
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-01-28
Primary Code
005
First Use Anywhere Date
2017-02-21
First Use In Commerce Date
2017-02-21
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Christopher M. Thomas
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0077290
Original Filing Date USPTO
2018-07-10
International Registration Number
1423104
International Registration Date
2018-07-10
International Status Code
480
International Renewal Date
2028-07-10
Madrid History Events
DateCodeDescription
2018-07-10NEWAPNEW APPLICATION FOR IR RECEIVED
2018-07-10ACERTAUTOMATICALLY CERTIFIED
2018-07-10APPSTIR CERTIFIED AND SENT TO IB
2018-09-13CREATAPPLICATION FOR IR REGISTERED BY IB
Trademark Events
Event DateEvent Description
2018-01-19NEW APPLICATION ENTERED IN TRAM
2018-01-28NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-01-30NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-04-26ASSIGNED TO EXAMINER
2018-05-01EXAMINERS AMENDMENT -WRITTEN
2018-05-01EXAMINERS AMENDMENT E-MAILED
2018-05-01NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2018-05-01EXAMINER'S AMENDMENT ENTERED
2018-05-01APPROVED FOR PUB - PRINCIPAL REGISTER
2018-05-11ASSIGNED TO LIE
2018-05-11LAW OFFICE PUBLICATION REVIEW COMPLETED
2018-05-30NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-06-19PUBLISHED FOR OPPOSITION
2018-06-19OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-08-14NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-02-07TEAS EXTENSION RECEIVED
2019-02-07EXTENSION 1 FILED
2019-02-07EXTENSION 1 GRANTED
2019-02-09NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-08-09TEAS EXTENSION RECEIVED
2019-08-09EXTENSION 2 FILED
2019-08-09EXTENSION 2 GRANTED
2019-08-13NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-02-10TEAS EXTENSION RECEIVED
2020-02-10EXTENSION 3 FILED
2020-02-10EXTENSION 3 GRANTED
2020-02-12NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-08-05TEAS EXTENSION RECEIVED
2020-08-05EXTENSION 4 FILED
2020-08-05EXTENSION 4 GRANTED
2020-08-07NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-02-10TEAS STATEMENT OF USE RECEIVED
2021-02-10TEAS EXTENSION RECEIVED
2021-02-25CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-02-10EXTENSION 5 FILED
2021-02-25EXTENSION 5 GRANTED
2021-02-10USE AMENDMENT FILED
2021-02-25STATEMENT OF USE PROCESSING COMPLETE
2021-02-26NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-03-01ASSIGNED TO LIE
2021-03-18SU - NON-FINAL ACTION - WRITTEN
2021-03-18NON-FINAL ACTION E-MAILED
2021-03-18NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-07-26TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-07-26CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-07-27TEAS/EMAIL CORRESPONDENCE ENTERED
2021-08-26SU - FINAL REFUSAL - WRITTEN
2021-08-26FINAL REFUSAL E-MAILED
2021-08-26NOTIFICATION OF FINAL REFUSAL EMAILED